Clinical Trials Sponsored by Diabetes Australia

Total 5264 results

Valneva Austria GmbH

Completed

Long Term Persistence and Effect of a Booster Dose of the Japanese Encephalitis Vaccine IC51

Japanese Encephalitis
Valneva Austria GmbH

Completed

Virological Response Study of the HCV Vaccine IC41

Chronic Hepatitis C

Germany, Poland, Romania
Diabetis JSC

Recruiting

FeetSee Thermal Images Collection Protocol

Diabetic Foot

Lithuania
Sansum Diabetes Research Institute

Recruiting

Community-Based Nutrition-Lifestyle Therapy for Pregnant Latina Women With Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mel Gestational - in Pregnancy

United States
Steno Diabetes Center Copenhagen

Recruiting

Low-Dose Glucagon and Advanced Hybrid Closed-Loop System for Prevention of Exercise-Induced Hypoglycaemia in People With Type 1 Diabetes (The HYPO-AVOID)

Hypoglycemia | Type 1 Diabetes

Denmark
LMC Diabetes & Endocrinology Ltd.

Recruiting

Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)

Type 2 Diabetes | Nonalcoholic Steatohepatitis

Canada
Atlanta Diabetes Associates
Medtronic

Recruiting

Evaluation of Medtronic DUO Extended Set

Diabetes Mellitus, Type 1

United States
Steno Diabetes Center Copenhagen

Completed

The Steno 780G Study

Type 1 Diabetes

Denmark
Scripps Whittier Diabetes Institute

Completed

Cardiometabolic Care-team Integration Improves Outcomes in Diabetes

Cardio-metabolic Care-Team Intervention (CMC-TI)
Steno Diabetes Center Copenhagen

Completed

Glycaemia and Cardiac Function in Patients With COVID-19 (GLYCOVID-19)

Diabetes Mellitus, Type 2 | Diabetes Mellitus | Diabetes Mellitus, Type 1 | COVID

Denmark
Steno Diabetes Center Copenhagen

Completed

Pen-Administered Low-Dose Dasiglucagon for Prevention and Treatment of Hypoglycemia in People With Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes

Denmark
Steno Diabetes Center Copenhagen

Active, not recruiting

Acute Changes in Plasma Glucose and Cardiovascular Disease in Diabetes

Hyperglycemia | Cardiovascular Diseases | Hypoglycemia | Diabetes | Sudden Cardiac Death

Denmark
Steno Diabetes Center Copenhagen

Completed

Acute Effects of Oral Ketone Ester on Cardiac Function in Patients With COVID-19 (KetoCOVID)

COVID-19

Denmark
Steno Diabetes Center Copenhagen

Withdrawn

Real Life Evaluation of SGLT2 Use in Type 1 Diabetes (RESGUE1)

Diabetic Ketoacidosis

Denmark
Scripps Whittier Diabetes Institute

Completed

Managing Type 1 and High Risk Type 2 Diabetes in the Hospital Setting: Glucose as a Vital Sign (Pilot Hosp CGM)

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Steno Diabetes Center Copenhagen

Completed

Cardiovascular Effects of Exercise-related Hypoglycaemia in Patients With Type 1 Diabetes (Hypo Heart Exercise)

Diabetes Mellitus, Type 1 | Arrhythmia

Denmark
LMC Diabetes & Endocrinology Ltd.

Completed

The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians (VARIATION 2 SA)

Diabetes Mellitus, Type 2

Canada
Steno Diabetes Center Copenhagen

Completed

Low-dose Dasiglucagon for Prevention of Insulin-Induced Hypoglycemia in People With Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes

Denmark
Texas Diabetes & Endocrinology, P.A.

Completed

FIasp® vs. Novolog® in Type 1 Diabetics Using 670G Medtronic Pump

Type 1 Diabetes Mellitus

United States
Steno Diabetes Center Copenhagen

Unknown

Effect of Glucagon-like Peptide 2 on Gallbladder Motility After a Meal in Young, Healthy Male Subjects

Effect of Glucagon-like Peptide 2 on Gallbladder Motility

Denmark
LMC Diabetes & Endocrinology Ltd.

Completed

Real-world Health Outcomes in Canadian Patients Using Semaglutide

Type 2 Diabetes

Canada
Sansum Diabetes Research Institute

Completed

Feasibility Study Using Run-to-Run Control to Optimize Continuous Glucose Sensor Bias

Diabetes

United States
Joslin Diabetes Center
Sanofi

Completed

Simplified Insulin Protocol Using Lantus in Elderly (SIMPLE)

Diabetes

United States
LMC Diabetes & Endocrinology Ltd.

Completed

Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study (ALT)

Fatty Liver | NAFLD | T2DM (Type 2 Diabetes Mellitus)

Canada
Sansum Diabetes Research Institute

Completed

Performance Evaluation of a Non-Invasive Glucose Monitor as Compared to CGM Data Acquired by the iPro2

Type 1 Diabetes

United States
Steno Diabetes Center Copenhagen

Completed

Study of 24 Hour Blood Pressure and the Association to Complications to Type 1 Diabetes (PROFIL)

Hypertension | Type 1 Diabetes

Denmark
Deutsche Diabetes Gesellschaft
Bayer

Completed

Blood Glucose Self Monitoring and HbA1c Effects on Glucose Control

Type 2 Diabetes

Germany
Tandem Diabetes Care, Inc.

Completed

Validation Study of G4 User Interface (G4)

Diabetes Mellitus
Steno Diabetes Center Copenhagen

Completed

Effect of Repaglinide Versus Metformin Treatment in Non-Obese Patients With Type-2-Diabetes

Diabetes Mellitus, Type 2

Denmark
Steno Diabetes Center Copenhagen

Completed

Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet

Diabetes Mellitus, Type 1
Steno Diabetes Center Copenhagen

Completed

Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy

Hypertension
Steno Diabetes Center Copenhagen

Completed

Maximal Dose of Angiotensin Converting Enzyme (ACE) Inhibitor for Treatment of Diabetic Kidney Disease

Diabetic Nephropathy | Diabetes Mellitus, Type I

Denmark
Valneva Austria GmbH

Recruiting

Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy Adults

Zika | Zika Virus Infection

United States
Austral University, Argentina

Recruiting

Effects of Receptive Music Therapy Combined With Virtual Reality on Prevalent Symptoms in Patients With Advanced Cancer

Music Therapy

Argentina
Austral University, Argentina

Recruiting

Cardiometabolic Risk Factors Registry (CARFARE)

Cardiovascular Diseases | Obesity | Diabetes | Atherosclerosis | Metabolic Syndrome | Cardiovascular Risk Factor

Argentina
Valneva Austria GmbH

Completed

Immunogenicity Study of the Japanese Encephalitis Vaccine IC51

Japanese Encephalitis
Valneva Austria GmbH

Completed

COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222 (COV-COMPARE)

SARS-CoV-2 Virus Infection

United Kingdom
Valneva Austria GmbH

Active, not recruiting

Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine Candidate (VLA1553)

Chikungunya Virus Infection

United States
Austral University, Argentina

Unknown

Re-linkage to Care of Patients With Hepatitis C

Viral Hepatitis C

Argentina
Valneva Austria GmbH

Completed

Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers

Chikungunya

United States
Austral University, Argentina

Unknown

Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV.

Hepatitis C | Cirrhosis | Antiviral Drug Adverse Reaction

Argentina
Valneva Austria GmbH

Completed

Immunogenicity of a Commercial Batch of JEV IC51 up to 24 Months Post Filling

Japanese Encephalitis

Germany, Austria
Valneva Austria GmbH

Completed

Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51

Japanese Encephalitis
Valneva Austria GmbH

Completed

Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51

Japanese Encephalitis
Valneva Austria GmbH

Completed

Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers

Healthy

Austria, Germany
Valneva Austria GmbH

Completed

This is a Study to Assess the Safety and Immunogenicity of Ixiaro® (IC51) in an Elderly Population

Japanese Encephalitis

Germany, Austria
Multitude Therapeutics (Australia) Pty Ltd

Not yet recruiting

AMT-562 in Patients With Selected Advanced Solid Tumors

Advanced Solid Tumors

Australia
Elpiscience Biopharma Australia Pty. Ltd.

Recruiting

A Study of ES009 in Subjects With Locally Advanced or Metastatic Solid Tumors

Advanced Solid Tumor

Australia
Multitude Therapeutics (Australia) Pty Ltd

Recruiting

AMT-253 in Patients With Selected Advanced Solid Tumours

Advanced Solid Tumor

Australia
Carmot Australia First Pty Ltd
Carmot Therapeutics, Inc.

Recruiting

Phase 1 Study of CT-996 in Overweight/Obese Participants and Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes | Overweight or Obesity

Australia

Clinical Trials Sponsored by Diabetes Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations